PDS Biotechnology Total Assets (Quarterly) Insights

PDS Biotechnology Corp (PDSB)

3.72 -0.10 (-2.62%) USD | NASDAQ | May 06, 16:00

3.72 0.00 (0.00%) After-Hours: 20:00

Total Assets (Quarterly) Chart

Historical Total Assets (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
December 31, 2023	59.39M
September 30, 2023	57.19M
June 30, 2023	63.75M
March 31, 2023	68.45M
December 31, 2022	77.01M
September 30, 2022	74.89M
June 30, 2022	56.00M
March 31, 2022	61.04M
December 31, 2021	67.20M
September 30, 2021	71.75M
June 30, 2021	77.39M
March 31, 2021	27.76M
December 31, 2020	30.89M
September 30, 2020	34.45M
June 30, 2020	20.09M
March 31, 2020	23.93M
December 31, 2019	14.49M
September 30, 2019	19.38M

Date	Value
June 30, 2019	25.80M
March 31, 2019	31.05M
December 31, 2018	36.22M
September 30, 2018	37.67M
June 30, 2018	47.21M
March 31, 2018	76.61M
December 31, 2017	92.62M
September 30, 2017	101.24M
June 30, 2017	112.99M
March 31, 2017	99.90M
December 31, 2016	110.91M
September 30, 2016	116.58M
June 30, 2016	115.42M
March 31, 2016	123.77M
December 31, 2015	134.09M
September 30, 2015	58.48M
June 30, 2015	62.69M
December 31, 2014	16.85M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

14.49M

Minimum

Dec 2019

77.39M

Maximum

Jun 2021

48.99M

Average

57.19M

Median

Sep 2023

Total Assets (Quarterly) Benchmarks

Syros Pharmaceuticals Inc	168.17M
PAVmed Inc	33.12M
Altimmune Inc	210.64M
Regeneron Pharmaceuticals Inc	34.37B
iBio Inc	34.02M

Total Assets (Quarterly) Related Metrics

Total Liabilities (Quarterly)	33.26M
Shareholders Equity (Quarterly)	26.13M